English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A prospective interventional study was conducted to see the efficacy and safety of a ophthalmic preparation olopatadine hydrochloride (0.1%) on 40 allergic conjunctivitis patients attended the out-patient department of Ophthalmology, Sylhet M.A.G. Osmani Medical College Hospital. One drop of ophthalmic solution was administered 12 hourly in each eye for 2 weeks. Scoring of hyperaemia, itching, tearing, and photophobia were estimated before and 2 weeks after administration of the drug. After 30 min. & 2 weeks of administration of drug adverse effects were assessed if there was any. The mean scores of hyperaemia, tearing, itching and photophobia were reduced after 2 weeks of treatment. The scores of hyperaemia, itching, tearing, photophobia were found to be lower compared to Day 0. This change was statistically significant (p < 0.001). Olopatadine appeared to reduce ocular signs and symptoms in Allergic conjunctivitis . Key words: Olopatadine hydrochloride; Allergic conjunctivitis; Hyperaemia; Tearing; Itching; Photophobia. DOI: 10.3329/medtoday.v22i1.5599 Medicine Today Vol.22(1) 2010. 15-19

A study on the Therapeutic Efficacy of Olopatadine Hydrochloride in the Management of Allergic Conjunctivitis